Skip to main content

Table 2 Relationship between clinical features of pancreatic cancer and the miR-221-3p content determined by RT-qPCR

From: MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological value

Characteristics

N

M ± SD

p

Tissues

 Adjacent non-cancerous tissues

16

9.603 ± 1.129

< 0.0001*

 Pancreatic cancer

16

12.422 ± 1.147

 

Age (years)

 < 60

5

12.87 ± 1.040

0.3038

 ≥ 60

11

12.22 ± 1.179

 

Gender

 Male

8

12.40 ± 1.202

0.9533

 Female

8

12.44 ± 1.172

 

Tumor size(cm)

 ≤3

6

12.10 ± 0.902

0.4093

 >3

10

12.61 ± 1.278

 

smoke

 No

11

12.58 ± 1.217

0.4346

 Yes

5

12.08 ± 1.007

 

Lymphatic Metastasis

 No

7

12.06 ± 1.070

0.2834

 Yes

9

12.70 ± 1.186

 

Vital status

 Live

3

11.61 ± 0.037

0.1832

 Death

13

12.61 ± 1.201

 

Stage

 Stage I–II

8

12.81 ± 1.337

0.1836

 Stage III–IV

8

12.03 ± ±0.827

 

Vascular invasion

 No

5

12.77 ± 1.360

0.4338

 Yes

11

12.26 ± 1.070

 

Histological type

 Pancreatic ductal adenocarcinoma

15

12.482 ± 1.160

0.0061*

 Undifferentiated cancer

1

11.516

 

Nerve invasion

 No

2

12.92 ± 1.905

0.528

 Yes

14

12.35 ± 1.093

 

Diabetes

 No

13

12.04 ± 0.850

0.0016*

 Yes

3

14.09 ± 0.617

 
  1. N indicates number, SD indicates standard deviation, M indicates mean, *indicates significant difference defined as p < 0.05